ST. PAUL, Minn. & ORLANDO, Fla.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced that five abstracts focusing on advances in the treatment of Peripheral Arterial Disease (PAD) and Coronary Arterial Disease (CAD) will be presented at the upcoming C3 Conference (Complex Cardiovascular Catheter). The abstracts will highlight data from CSI trials focused on the clinical and economic benefits of using its Orbital Atherectomy technology to treat patients with calcified lesions. The conference is taking place June 19–23 in Orlando, Fla.
